Search results
Scientists find potential treatment target for leading cause of blindness
Investing.com· 1 day agoNew Delhi, May 2 (IANS) US scientists have found answers to why treatment for neovascular...
Regeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales
Zacks via Yahoo Finance· 22 hours agoIn August 2023, the FDA approved Eylea HD (higher dose of Eylea) for the treatment of patients with...
ISS National Laboratory welcomes return to earth of projects
Electronics Weekly· 7 hours agoThe ISS National Laboratory is highlighting the return to earth of a range of projects that have...
California Public Employees Retirement System Sells 38,011 Shares of Apellis Pharmaceuticals, Inc....
ETF DAILY NEWS· 6 hours agoCalifornia Public Employees Retirement System reduced its holdings in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 20.7% in the fourth quarter, according to the company in its ...
Stealth BioTherapeutics Announces Participation at Upcoming Ophthalmology Conferences
WDTN-TV 2 Dayton· 2 days agoAt the OIS Retina Innovation...
Can You Take Vitamin C and Iron Together?
Health via Yahoo News· 3 days agoIron is often sold in products that also contain vitamin C. Vitamin C can enhance iron absorption, but, as with all supplements, there are...
Obituaries in Topeka, KS | Topeka Capital-Journal
The Topeka Capital-Journal· 18 hours agoMargery Adeana McClacherty at the age of 96 peacefully passed away on April 27, 2024. Margery was born on September 10, 1927, in Bellingham, Washington; daughter of the late Guy William and ...
EYLEA HD shows promise in long-term clinical trials By Investing.com
Investing.com· 4 days agoThe data includes one-year outcomes from the PHOTON trial, which studied EYLEA HD in patients with...
Regeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales
Zacks· 1 day agoRegeneron (REGN) reports Q1 results, wherein both the top and bottom lines miss estimates due to lower Eylea sales. Shares down.
Johnson & Johnson (NYSE:JNJ) Shares Purchased by Telemus Capital LLC
ETF DAILY NEWS· 5 days agoTelemus Capital LLC increased its stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 0.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange ...
